The hand eczema proteome: Imbalance of epidermal barrier proteins

British Journal of Dermatology

Volumn 172, Issue 4, 2015, Pages 994-1001

  Molin, S ^a,b   Merl, J ^b   Dietrich, K A ^a   Regauer, M ^c   Flaig, M ^a   Letule V ^a   Saucke, T ^a   Herzinger, T ^a   Ruzicka, T ^a   Hauck, S M ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CYSTATIN M; FILAGGRIN; FILAGGRIN 2; HORNERIN; KALLIKREIN RELATED PEPTIDASE 5; KALLIKREIN RELATED PEPTIDASE 7; PROLINE RICH PROTEIN 2B; PROTEIN S100 A11; PROTEOME; PSORIASIN; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; CORNIFIED ENVELOPE LIKE PROLINE RICH PROTEIN; CYSTATIN; FILAGGRIN-2 PROTEIN, HUMAN; HRNR PROTEIN, HUMAN; INTERMEDIATE FILAMENT PROTEIN; KALLIKREIN; KLK5 PROTEIN, HUMAN; KLK7 PROTEIN, HUMAN; PROTEIN S 100;

ADULT; ARTICLE; CHRONIC HAND ECZEMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HAND ECZEMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKIN EXFOLIATION; STRATUM CORNEUM; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; UPREGULATION; CASE CONTROL STUDY; CHRONIC DISEASE; ECZEMA; EPIDERMIS; HAND DERMATOSES; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY;

ADULT; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; CHRONIC DISEASE; CORNIFIED ENVELOPE PROLINE-RICH PROTEINS; CYSTATINS; DOWN-REGULATION; ECZEMA; EPIDERMIS; FEMALE; HAND DERMATOSES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KALLIKREINS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOME; S100 PROTEINS; UP-REGULATION;

EID: 84926170304     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13418     Document Type: Article

References (36)

1. Coenraads PJ,. Hand eczema is common and multifactorial. J Invest Dermatol 2007; 127: 1568-70.
2. Agner T, Andersen KE, Brandao FM, et al,. Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis 2008; 59: 43-7.
3. Agner T, Andersen KE, Brandao FM, et al,. Contact sensitisation in hand eczema patients-relation to subdiagnosis, severity and quality of life: a multi-centre study. Contact Dermatitis 2009; 61: 291-6.
4. Coenraads PJ,. Hand eczema. N Engl J Med 2012; 367: 1829-37.
5. Molin S, Diepgen TL, Ruzicka T, Prinz JC,. Diagnosing chronic hand eczema by an algorithm: a tool for classification in clinical practice. Clin Exp Dermatol 2011; 36: 595-601.
6. Augustin M, Kuessner D, Purwins S, et al,. Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany. Br J Dermatol 2011; 165: 845-51.
7. Bingefors K, Lindberg M, Isacson D,. Quality of life, use of topical medications and socio-economic data in hand eczema: a Swedish nationwide survey. Acta Derm Venereol 2011; 91: 452-8.
8. Diepgen TL, Purwins S, Posthumus J, et al,. Cost-of-illness analysis of patients with chronic hand eczema in routine care in Germany: focus on the impact of occupational disease. Acta Derm Venereol 2013; 93: 538-43.
9. Diepgen TL, Elsner P, Schliemann S, et al,. Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 2009; 7 (Suppl. 3): S1-16.
10. Molin S, Vollmer S, Weiss EH, et al,. Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis. Br J Dermatol 2009; 161: 801-7.
11. Molin S, Vollmer S, Weiss EH, et al,. Deletion of the late cornified envelope genes LCE3B and LCE3C may promote chronic hand eczema with allergic contact dermatitis. J Investig Allergol Clin Immunol 2011; 21: 472-9.
12. Landeck L, Visser M, Skudlik C, et al,. Clinical course of occupational irritant contact dermatitis of the hands in relation to filaggrin genotype status and atopy. Br J Dermatol 2012; 167: 1302-9.
13. Lan CC, Tu HP, Wu CS, et al,. Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population. Exp Dermatol 2011; 20: 975-9.
14. Wisniewski JR, Zougman A, Nagaraj N, Mann M,. Universal sample preparation method for proteome analysis. Nat Methods 2009; 6: 359-62.
15. Hauck SM, Dietter J, Kramer RL, et al,. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol Cell Proteomics 2010; 9: 2292-305.
16. Hahne H, Pachl F, Ruprecht B, et al,. DMSO enhances electrospray response, boosting sensitivity of proteomic experiments. Nat Methods 2013; 10: 989-91.
17. Merl J, Ueffing M, Hauck SM, von Toerne C,. Direct comparison of MS-based label-free and SILAC quantitative proteome profiling strategies in primary retinal Muller cells. Proteomics 2012; 12: 1902-11.
18. Pellerin L, Henry J, Hsu CY, et al,. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol 2013; 131: 1094-102.
19. Wu Z, Hansmann B, Meyer-Hoffert U, et al,. Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family. PLoS One 2009; 4: e5227.
20. Wolf R, Ruzicka T, Yuspa SH,. Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function. Amino Acids 2011; 41: 789-96.
21. Glaser R, Meyer-Hoffert U, Harder J, et al,. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009; 129: 641-9.
22. Scola N, Gambichler T, Saklaoui H, et al,. The expression of antimicrobial peptides is significantly altered in cutaneous squamous cell carcinoma and precursor lesions. Br J Dermatol 2012; 167: 591-7.
23. Ehrchen JM, Sunderkotter C, Foell D, et al,. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009; 86: 557-66.
24. Abtin A, Eckhart L, Glaser R, et al,. The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes. J Invest Dermatol 2010; 130: 2423-30.
25. Kypriotou M, Huber M, Hohl D,. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family. Exp Dermatol 2012; 21: 643-9.
26. Margolis DJ, Gupta J, Apter AJ, et al,. Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. J Allergy Clin Immunol 2014; 133: 784-9.
27. Visser MJ, Verberk MM, Campbell LE, et al,. Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study. Contact Dermatitis 2014; 70: 139-50.
28. Kezic S, O'Regan GM, Yau N, et al,. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy 2011; 66: 934-40.
29. de Koning HD, van den Bogaard EH, Bergboer JG, et al,. Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. Br J Dermatol 2012; 166: 1245-54.
30. Kerkhoff C, Voss A, Scholzen TE, et al,. Novel insights into the role of S100A8/A9 in skin biology. Exp Dermatol 2012; 21: 822-6.
31. Petersen B, Wolf M, Austermann J, et al,. The alarmin Mrp8/14 as regulator of the adaptive immune response during allergic contact dermatitis. EMBO J 2013; 32: 100-11.
32. Meyer-Hoffert U, Wu Z, Schroder JM,. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor. PLoS One 2009; 4: e4372.
33. Fischer J, Wu Z, Kantyka T, et al,. Characterization of spink6 in mouse skin: the conserved inhibitor of kallikrein-related peptidases is reduced by barrier injury. J Invest Dermatol 2014; 134: 1305-12.
34. Howell MD, Fairchild HR, Kim BE, et al,. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128: 2248-58.
35. Zeeuwen PL, Ishida-Yamamoto A, van Vlijmen-Willems IM, et al,. Colocalization of cystatin M/E and cathepsin V in lamellar granules and corneodesmosomes suggests a functional role in epidermal differentiation. J Invest Dermatol 2007; 127: 120-8.
36. Cheng T, Tjabringa GS, van Vlijmen-Willems IM, et al,. The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis. Br J Dermatol 2009; 161: 253-64.